Fortis Healthcare

Fortis Healthcare Limited is one of India's largest and most prominent integrated healthcare delivery systems, operating a network of over 40 hospitals, more than 55 diagnostic centres, and approximately 10,000 beds across India, with operations also in Singapore, Sri Lanka, and other international markets. Founded in 2001, Fortis has grown to become a globally recognised brand in healthcare delivery, serving over 5 million patients annually.

Headquartered in Gurugram (Gurgaon), Haryana, Fortis Healthcare is listed on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE). IHH Healthcare — one of the world's largest healthcare groups with operations across Malaysia, Singapore, Turkey, and India — has a significant strategic interest in Fortis, bringing international governance standards and clinical expertise to the network. This partnership has accelerated Fortis's technology investments and quality improvement initiatives.

Fortis is particularly renowned for its Centres of Excellence in cardiac sciences, oncology, neurosciences, orthopaedics, organ transplantation, bone marrow transplantation, and women's health. Its flagship hospital — Fortis Memorial Research Institute (FMRI) in Gurgaon — holds Joint Commission International (JCI) accreditation, the global gold standard in hospital quality, and is among the most advanced multi-specialty hospitals in Asia. Fortis's comprehensive international patient services programme makes it a leading destination for medical tourism from Africa, the Gulf, South Asia, and the Indian diaspora worldwide.

Fortis Healthcare's clinical programmes span the entire spectrum of tertiary and quaternary care. The group's Centres of Excellence include cardiac sciences (interventional cardiology, electrophysiology, adult cardiac surgery, paediatric cardiac surgery, heart failure management), oncology and haematology (medical oncology, surgical oncology, radiation oncology, CAR-T cell therapy, bone marrow transplantation), neurosciences (neurology, neurosurgery, neuroradiology, deep brain stimulation, stroke programme), organ transplantation (liver, kidney, heart, lung, pancreas, composite tissue), orthopaedics (joint replacement, arthroscopy, spine surgery, sports medicine), nephrology and kidney transplantation, gastroenterology and hepatology, pulmonology and chest medicine, endocrinology and diabetes, obstetrics and gynaecology, women and child health, paediatrics and neonatology, plastic and reconstructive surgery, and bariatric surgery.

Fortis's Escorts Heart Institute (Okhla, New Delhi) and Fortis Memorial Research Institute (Gurgaon) are among the most cited centres in their respective fields in Indian medical literature. The group's robotic surgery programme — using da Vinci surgical systems across multiple hospitals — enables complex procedures in urology, gynaecology, colorectal surgery, and general surgery with smaller incisions and faster patient recovery times.

Across its network of over 40 hospitals and approximately 10,000 beds, Fortis Healthcare maintains consistently high technology standards. Key facilities across the network include cardiac catheterisation and electrophysiology laboratories, hybrid operating theatres, da Vinci robotic surgery systems, CyberKnife and Tomotherapy radiosurgery systems, linear accelerators (LINACs) for radiation oncology, PET-CT scanners for oncological staging, 3T MRI scanners, 128-slice and dual-source CT scanners, dedicated bone marrow transplant units with HEPA-filtered isolation rooms, level 3 NICUs, full-service blood banks with apheresis capability, NABL-accredited clinical laboratories, 24-hour emergency and trauma departments, comprehensive pharmacy services, and physiotherapy and rehabilitation centres.

Fortis Healthcare's digital health initiative enables patient records to be shared across all network hospitals through a centralised health records system, supporting continuity of care for patients who access multiple Fortis facilities. International patients benefit from standardised electronic medical records that can be shared securely with overseas referring physicians, facilitating post-treatment follow-up in the patient's home country.

Fortis Healthcare operates a dedicated International Patient Services Centre (FIPSC) that provides comprehensive end-to-end support for overseas patients accessing any Fortis hospital across India. The FIPSC can be reached at fipsc@fortishealthcare.com and +91-11-42295282, and is staffed by multilingual coordinators experienced in managing patients from over 50 countries.

International patient services include pre-arrival specialist teleconsultations, medical report and imaging review by Fortis specialists, itemised treatment cost estimates, medical visa invitation letters, airport transfer coordination, accommodation assistance at partner hotels near Fortis facilities, in-hospital international patient lounges, language interpretation services in Arabic, French, Swahili, Russian, Bangla, and other languages, dietary support for different cultural needs, and comprehensive discharge documentation with all reports.

Fortis serves a large international patient base from West Africa (Nigeria, Ghana), East Africa (Kenya, Tanzania, Uganda, Ethiopia), the Gulf region (UAE, Saudi Arabia, Kuwait, Oman, Qatar), South Asia (Bangladesh, Nepal, Sri Lanka, Afghanistan), and Central Asia. Treatment costs across Fortis hospitals are 60-80% lower than equivalent care in the UK, USA, or Western Europe, making Fortis a leading destination for high-quality, affordable tertiary care.

Multiple Fortis Healthcare hospitals hold NABH (National Accreditation Board for Hospitals and Healthcare Providers) accreditation — India's national hospital quality standard — ensuring comprehensive clinical governance across patient safety, infection control, nursing care, medical records, and hospital administration. Fortis Memorial Research Institute (FMRI) Gurgaon holds JCI (Joint Commission International) accreditation, the global gold standard for hospital quality recognised in over 100 countries.

Fortis Healthcare has received numerous national and international recognitions including awards from Business Today and Nielsen for best hospitals in India, recognition from various specialty bodies for cardiac, oncology, and orthopaedic outcomes, and Forbes Asia recognition. The group's diagnostic division holds NABL (National Accreditation Board for Testing and Calibration Laboratories) certification for its pathology and imaging laboratories.

As a BSE and NSE listed company, Fortis Healthcare maintains full SEBI-compliant corporate governance and financial disclosure standards. The group's collaboration with IHH Healthcare brings international clinical governance oversight. All Fortis hospitals comply with the Clinical Establishments (Registration and Regulation) Act and applicable state healthcare regulations.